Provider: Nature Publishing Group
Content: application/x-research-info-systems
TY  - JOUR
AU  - Deininger, M.
AU  - Buchdunger, E.
AU  - Druker, B. J.
TI  - The development of imatinib as a therapeutic agent for chronic myeloid leukemia
JA  - Blood
PY  - 2005///
VL  - 1
SP  - 2640
EP  - 2653
M3  - 10.1182/blood-2004-08-3097
N1  - 10.1182/blood-2004-08-3097
UR  - http://dx.doi.org/10.1182/blood-2004-08-3097
ER  -

TY  - JOUR
AU  - Emens, L. A.
TI  - Trastuzumab: targeted therapy for the management of HER-2/neu-overexpressing metastatic breast cancer
JA  - Am. J. Ther.
PY  - 2005///
VL  - 12
SP  - 243
EP  - 253
ER  -

TY  - JOUR
AU  - Weinstein, I.
TI  - Addiction to oncogenes: the Achilles Heel of Cancer
JA  - Science
PY  - 2002///
VL  - 297
SP  - 63
EP  - 65
M3  - 10.1126/science.1073096
N1  - 10.1126/science.1073096
UR  - http://dx.doi.org/10.1126/science.1073096
ER  -

TY  - JOUR
AU  - Hartwell, L. H.
AU  - Szankasi, P.
AU  - Roberts, C. J.
AU  - Murray, A. W.
AU  - Friend, S. H.
TI  - Integrating genetic approaches into the discovery of anticancer drugs
JA  - Science
PY  - 1997///
VL  - 278
SP  - 1064
EP  - 1068
M3  - 10.1126/science.278.5340.1064
N1  - 10.1126/science.278.5340.1064
UR  - http://dx.doi.org/10.1126/science.278.5340.1064
ER  -

TY  - JOUR
AU  - Kaelin, W. J., 
TI  - The concept of synthetic lethality in the context of anticancer therapy
JA  - Nature Rev. Cancer
PY  - 2005///
VL  - 5
SP  - 689
EP  - 698
M3  - 10.1038/nrc1691
N1  - 10.1038/nrc1691
UR  - http://dx.doi.org/10.1038/nrc1691
ER  -

TY  - JOUR
AU  - Farmer, H.
TI  - Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
JA  - Nature
PY  - 2005///
VL  - 434
SP  - 917
EP  - 921
M3  - 10.1038/nature03445
N1  - 10.1038/nature03445
UR  - http://dx.doi.org/10.1038/nature03445
ER  -

TY  - JOUR
AU  - Mills, G. P.
AU  - Lu, Y.
AU  - Kohn, E. C.
TI  - Linking molecular therapeutics to molecular diagnostics: inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo
JA  - Proc. Natl Acad. Sci. USA
PY  - 2001///
VL  - 98
SP  - 10031
EP  - 10033
M3  - 10.1073/pnas.191379498
N1  - 10.1073/pnas.191379498
UR  - http://dx.doi.org/10.1073/pnas.191379498
ER  -

TY  - JOUR
AU  - O'Neill, J.
AU  - Manion, M.
AU  - Schwartz, P.
AU  - Hockenbery, D. M.
TI  - Promises and challenges of targeting Bcl-2 anti-apoptotic proteins for cancer therapy
JA  - Biochim. Biophys. Acta
PY  - 2004///
VL  - 1705
SP  - 43
EP  - 51
ER  -

TY  - JOUR
AU  - Jensen, E. V.
AU  - Jordan, V. C.
TI  - The estrogen receptor: a model for molecular medicine
JA  - Clin. Cancer Res.
PY  - 2003///
VL  - 9
SP  - 1980
EP  - 1989
ER  -

TY  - JOUR
AU  - Jenster, G.
TI  - The role of the androgen receptor in the development and progression of prostate cancer
JA  - Semin. Oncol.
PY  - 1999///
VL  - 26
SP  - 407
EP  - 421
ER  -

TY  - JOUR
AU  - Pitha-Rowe, I.
AU  - Petty, W. J.
AU  - Kitareewan, S.
AU  - Dmitrovsky, E.
TI  - Retinoid target genes in acute promyelocytic leukemia
JA  - Leukemia
PY  - 2003///
VL  - 17
SP  - 1723
EP  - 1730
M3  - 10.1038/sj.leu.2403065
N1  - 10.1038/sj.leu.2403065
UR  - http://dx.doi.org/10.1038/sj.leu.2403065
ER  -

TY  - JOUR
AU  - Garraway, L. A.
TI  - Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
JA  - Nature
PY  - 2005///
VL  - 436
SP  - 117
EP  - 122
M3  - 10.1038/nature03664
N1  - 10.1038/nature03664
UR  - http://dx.doi.org/10.1038/nature03664
ER  -

TY  - JOUR
AU  - Marx, J.
TI  - Encouraging results for second generation anti-angiogenic drugs
JA  - Science
PY  - 2005///
VL  - 308
SP  - 1248
EP  - 1249
M3  - 10.1126/science.308.5726.1248
N1  - 10.1126/science.308.5726.1248
UR  - http://dx.doi.org/10.1126/science.308.5726.1248
ER  -

TY  - JOUR
AU  - van Elsas, A.
TI  - Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma
JA  - Am. J. Pathol.
PY  - 1996///
VL  - 149
SP  - 883
EP  - 893
ER  -

TY  - JOUR
AU  - Walker, F.
AU  - Olson, M. F.
TI  - Targeting Ras and Rho GTPases as opportunities for cancer therapies
JA  - Curr. Opin. Genet. Dev.
PY  - 2005///
VL  - 15
SP  - 62
EP  - 68
M3  - 10.1016/j.gde.2004.11.001
N1  - 10.1016/j.gde.2004.11.001
UR  - http://dx.doi.org/10.1016/j.gde.2004.11.001
ER  -

TY  - JOUR
AU  - Beeram, M.
AU  - Patnaik, A.
AU  - Rowinsky, E. K.
TI  - Raf: a strategic target for therapeutic development against cancer
JA  - J. Clin. Oncol.
PY  - 2005///
VL  - 23
SP  - 6771
EP  - 6790
M3  - 10.1200/JCO.2005.08.036
N1  - 10.1200/JCO.2005.08.036
UR  - http://dx.doi.org/10.1200/JCO.2005.08.036
ER  -

TY  - JOUR
AU  - Davies, H.
TI  - Mutations of the BRAF gene in human cancer
JA  - Nature
PY  - 2002///
VL  - 417
SP  - 949
EP  - 954
M3  - 10.1038/nature00766
N1  - 10.1038/nature00766
UR  - http://dx.doi.org/10.1038/nature00766
ER  -

TY  - JOUR
AU  - Pollock, P. M.
TI  - High frequency of BRAF mutations in nevi
JA  - Nature Genet.
PY  - 2003///
VL  - 33
SP  - 19
EP  - 20
M3  - 10.1038/ng1054
N1  - 10.1038/ng1054
UR  - http://dx.doi.org/10.1038/ng1054
ER  -

TY  - JOUR
AU  - Thompson, N.
AU  - Lyons, J.
TI  - Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery
JA  - Curr. Opin. Pharmacol.
PY  - 2005///
VL  - 5
SP  - 350
EP  - 356
ER  -

TY  - JOUR
AU  - Janne, P. A.
AU  - Engelman, J. A.
AU  - Johnson, B. E.
TI  - Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology
JA  - J. Clin. Oncol.
PY  - 2005///
VL  - 23
SP  - 3227
EP  - 3234
M3  - 10.1200/JCO.2005.09.985
N1  - 10.1200/JCO.2005.09.985
UR  - http://dx.doi.org/10.1200/JCO.2005.09.985
ER  -

TY  - JOUR
AU  - Paez, J. G.
TI  - EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy
JA  - Science
PY  - 2004///
VL  - 304
SP  - 1497
EP  - 500
M3  - 10.1126/science.1099314
N1  - 10.1126/science.1099314
UR  - http://dx.doi.org/10.1126/science.1099314
ER  -

TY  - JOUR
AU  - Rao, W.
TI  - EGF receptor gene mutations are common in lung cancers from [ldquo]never smokers[rdquo] and are associated with sensitivity of tumors to gefitinib and erlotinib
JA  - Proc. Natl Acad. Sci. USA
PY  - 2004///
VL  - 101
SP  - 13306
EP  - 13311
ER  -

TY  - JOUR
AU  - Tsao, M. S.
TI  - Erlotinib in lung cancer: molecular and clinical predictors of outcome
JA  - N. Engl. J. Med.
PY  - 2005///
VL  - 353
SP  - 133
EP  - 134
M3  - 10.1056/NEJMoa050736
N1  - 10.1056/NEJMoa050736
UR  - http://dx.doi.org/10.1056/NEJMoa050736
ER  -

TY  - JOUR
AU  - Patel, J. D.
AU  - Pasche, B.
AU  - Argiris, A.
TI  - Targeting non-small cell lung cancer with epidermal growth factor tyrosine kinase inhibitors: where do we stand, where do we go
JA  - Crit. Rev. Oncol. Hematol.
PY  - 2004///
VL  - 50
SP  - 175
EP  - 186
ER  -

TY  - JOUR
AU  - Mellinghoff, I. K.
TI  - Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
JA  - N. Engl. J. Med.
PY  - 2005///
VL  - 353
SP  - 2012
EP  - 2024
M3  - 10.1056/NEJMoa051918
N1  - 10.1056/NEJMoa051918
UR  - http://dx.doi.org/10.1056/NEJMoa051918
ER  -

TY  - JOUR
AU  - Engelman, J. A.
TI  - ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines
JA  - Proc. Natl Acad. Sci. USA
PY  - 2005///
VL  - 102
SP  - 3788
EP  - 3793
M3  - 10.1073/pnas.0409773102
N1  - 10.1073/pnas.0409773102
UR  - http://dx.doi.org/10.1073/pnas.0409773102
ER  -

TY  - JOUR
AU  - Shih, C.
AU  - Weinberg, R. A.
TI  - Isolation of a transforming sequence from a human bladder carcinoma cell line
JA  - Cell
PY  - 1982///
VL  - 29
SP  - 161
EP  - 169
M3  - 10.1016/0092-8674(82)90100-3
N1  - 10.1016/0092-8674(82)90100-3
UR  - http://dx.doi.org/10.1016/0092-8674(82)90100-3
ER  -

TY  - JOUR
AU  - Silva, J.
AU  - Chang, K.
AU  - Hannon, G. J.
AU  - Rivas, F. V.
TI  - RNA-interference-based functional genomics in mammalian cells: reverse genetics coming of age
JA  - Oncogene
PY  - 2004///
VL  - 23
SP  - 8401
EP  - 8409
M3  - 10.1038/sj.onc.1208176
N1  - 10.1038/sj.onc.1208176
UR  - http://dx.doi.org/10.1038/sj.onc.1208176
ER  -

TY  - JOUR
AU  - Torrance, C. J.
AU  - Agrawal, V.
AU  - Vogelstein, B.
AU  - Kinzler, K. W.
TI  - Use of isogenic human cancer cells for high-throughput screening and drug discovery
JA  - Nature Biotechnol.
PY  - 2001///
VL  - 19
SP  - 940
EP  - 945
M3  - 10.1038/nbt1001-940
N1  - 10.1038/nbt1001-940
UR  - http://dx.doi.org/10.1038/nbt1001-940
ER  -

TY  - JOUR
AU  - Kohli, M.
AU  - Rago, C.
AU  - Lengauer, C.
AU  - Kinzler, K. W.
AU  - Vogelstein, B.
TI  - Facile methods for generating human somatic cell gene knockouts using recombinant adeno-associated viruses
JA  - Nucleic Acids Res.
PY  - 2004///
VL  - 32
SP  - e3
M3  - 10.1093/nar/gnh009
N1  - 10.1093/nar/gnh009
UR  - http://dx.doi.org/10.1093/nar/gnh009
ER  -

TY  - JOUR
AU  - Mazurier, F.
AU  - Doedens, M.
AU  - Gan, O. I.
AU  - Dick, J. E.
TI  - Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells
JA  - Nature Med.
PY  - 2003///
VL  - 9
SP  - 959
EP  - 963
M3  - 10.1038/nm886
N1  - 10.1038/nm886
UR  - http://dx.doi.org/10.1038/nm886
ER  -

TY  - JOUR
AU  - Brumby, A. M.
AU  - Richardson, H. E.
TI  - Using Drosophila melanogaster to map human cancer pathways
JA  - Nature Rev. Cancer
PY  - 2005///
VL  - 5
SP  - 626
EP  - 639
M3  - 10.1038/nrc1671
N1  - 10.1038/nrc1671
UR  - http://dx.doi.org/10.1038/nrc1671
ER  -

TY  - JOUR
AU  - Amatruda, J. D.
AU  - Shepard, J. L.
AU  - Stern, H. M.
AU  - Zon, L. I.
TI  - Zebrafish as a cancer model system
JA  - Cancer Cell
PY  - 2002///
VL  - 1
SP  - 229
EP  - 231
M3  - 10.1016/S1535-6108(02)00052-1
N1  - 10.1016/S1535-6108(02)00052-1
UR  - http://dx.doi.org/10.1016/S1535-6108(02)00052-1
ER  -

TY  - JOUR
AU  - Simon, J. A.
TI  - Yeast as a model system for anticancer drug discovery
JA  - Expert Opin. Ther. Targets
PY  - 2001///
VL  - 5
SP  - 177
EP  - 195
M3  - 10.1517/14728222.5.2.177
N1  - 10.1517/14728222.5.2.177
UR  - http://dx.doi.org/10.1517/14728222.5.2.177
ER  -

TY  - JOUR
AU  - Hengartner, M. O.
AU  - Horvitz, H. R.
TI  - C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2
JA  - Cell
PY  - 1994///
VL  - 76
SP  - 665
EP  - 676
M3  - 10.1016/0092-8674(94)90506-1
N1  - 10.1016/0092-8674(94)90506-1
UR  - http://dx.doi.org/10.1016/0092-8674(94)90506-1
ER  -

TY  - JOUR
AU  - Kamb, A.
TI  - What's wrong with our cancer models?
JA  - Nature Rev. Drug Discov.
PY  - 2005///
VL  - 4
SP  - 161
EP  - 165
M3  - 10.1038/nrd1635
N1  - 10.1038/nrd1635
UR  - http://dx.doi.org/10.1038/nrd1635
ER  -

TY  - JOUR
AU  - Sausville, E. A.
TI  - Target selection issues in drug discovery and development
JA  - J. Chemother. Suppl.
PY  - 2004///
VL  - 16
IS  - suppl. 4
SP  - 16
EP  - 18
ER  -

TY  - JOUR
AU  - Samuels, Y.
TI  - High frequency of mutations of the PIK3CA gene in human cancers
JA  - Science
PY  - 2004///
VL  - 304
SP  - 554
M3  - 10.1126/science.1096502
N1  - 10.1126/science.1096502
UR  - http://dx.doi.org/10.1126/science.1096502
ER  -

TY  - JOUR
AU  - Bachman, K. E.
TI  - The PIK3CA gene is mutated with high frequency in human breast cancers
JA  - Cancer Biol. Ther.
PY  - 2004///
VL  - 3
SP  - 772
EP  - 775
ER  -

TY  - JOUR
AU  - Samuels, Y.
TI  - Mutant PIK3CA promotes cell growth and invasion of human cancer cells
JA  - Cancer Cell
PY  - 2005///
VL  - 7
SP  - 561
EP  - 573
M3  - 10.1016/j.ccr.2005.05.014
N1  - 10.1016/j.ccr.2005.05.014
UR  - http://dx.doi.org/10.1016/j.ccr.2005.05.014
ER  -

TY  - JOUR
AU  - Aoki, M.
AU  - Jiang, H.
AU  - Vogt, P. K.
TI  - Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins
JA  - Proc. Natl Acad. Sci. USA
PY  - 2004///
VL  - 101
SP  - 13613
EP  - 13617
M3  - 10.1073/pnas.0405454101
N1  - 10.1073/pnas.0405454101
UR  - http://dx.doi.org/10.1073/pnas.0405454101
ER  -

TY  - JOUR
AU  - Lengauer, C.
AU  - Diaz, L. A.
AU  - Saha, S.
TI  - Cancer drug discovery through collaboration
JA  - Nature Rev. Drug Discov.
PY  - 2005///
VL  - 4
SP  - 375
EP  - 380
M3  - 10.1038/nrd1722
N1  - 10.1038/nrd1722
UR  - http://dx.doi.org/10.1038/nrd1722
ER  -

TY  - JOUR
AU  - Salloukh, H. F.
AU  - Vowles, I.
AU  - Heisterkamp, N.
AU  - Groffen, J.
AU  - Laneuville, P.
TI  - Early events in leukemogenesis in P190Bcr-abl transgenic mice
JA  - Oncogene
PY  - 2000///
VL  - 19
SP  - 4362
EP  - 4374
M3  - 10.1038/sj.onc.1203804
N1  - 10.1038/sj.onc.1203804
UR  - http://dx.doi.org/10.1038/sj.onc.1203804
ER  -

TY  - JOUR
AU  - Lefevre, G.
TI  - Roles of stem cell factor/c-Kit and effects of Glivec/STI571 in human uveal melanoma cell tumorigenesis
JA  - J. Biol. Chem.
PY  - 2004///
VL  - 279
SP  - 31769
EP  - 31779
M3  - 10.1074/jbc.M403907200
N1  - 10.1074/jbc.M403907200
UR  - http://dx.doi.org/10.1074/jbc.M403907200
ER  -

TY  - JOUR
AU  - Mitsiades, C. S.
AU  - Mitsiades, N.
AU  - Koutsilieris, M.
TI  - The Akt pathway: molecular targets for anti-cancer drug development
JA  - Curr. Cancer Drug Targets
PY  - 2004///
VL  - 4
SP  - 235
EP  - 256
M3  - 10.2174/1568009043333032
N1  - 10.2174/1568009043333032
UR  - http://dx.doi.org/10.2174/1568009043333032
ER  -

TY  - JOUR
AU  - Kitayama, H.
TI  - Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase
JA  - Blood
PY  - 1996///
VL  - 88
SP  - 995
EP  - 1004
ER  -

TY  - JOUR
AU  - Cool, M.
AU  - Depault, F.
AU  - Jolicoeur, P.
TI  - Fine allelotyping of Erbb2-induced mammary tumors in mice reveals multiple discontinuous candidate regions of tumor-suppressor loci
JA  - Genes Chromosomes Cancer
PY  - 2006///
VL  - 45
SP  - 191
EP  - 202
M3  - 10.1002/gcc.20276
N1  - 10.1002/gcc.20276
UR  - http://dx.doi.org/10.1002/gcc.20276
ER  -

TY  - JOUR
AU  - Kang, C. S.
TI  - An in vitro study on the suppressive effect of glioma cell growth induced by plasmid-based small interference RNA (siRNA) targeting human epidermal growth factor receptor
JA  - J. Neurooncol.
PY  - 2005///
VL  - 73
SP  - 267
EP  - 273
M3  - 10.1007/s11060-004-8322-z
N1  - 10.1007/s11060-004-8322-z
UR  - http://dx.doi.org/10.1007/s11060-004-8322-z
ER  -

TY  - JOUR
AU  - Kim, H.
AU  - Muller, W. J.
TI  - The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis
JA  - Exp. Cell Res.
PY  - 1999///
VL  - 253
SP  - 78
EP  - 87
M3  - 10.1006/excr.1999.4706
N1  - 10.1006/excr.1999.4706
UR  - http://dx.doi.org/10.1006/excr.1999.4706
ER  -

TY  - JOUR
AU  - Early, E.
TI  - Transgenic expression of PML/RAR[alpha] impairs myelopoiesis
JA  - Proc. Natl Acad. Sci. USA
PY  - 1996///
VL  - 93
SP  - 7900
EP  - 7904
M3  - 10.1073/pnas.93.15.7900
N1  - 10.1073/pnas.93.15.7900
UR  - http://dx.doi.org/10.1073/pnas.93.15.7900
ER  -

TY  - JOUR
AU  - Park, D. J.
AU  - Vuong, P. T.
AU  - de Vos, S.
AU  - Douer, D.
AU  - Koeffler, H. P.
TI  - Comparative analysis of genes regulated by PML/RAR[alpha] and PLZF/RAR[alpha] in response to retinoic acid using oligonucleotide arrays
JA  - Blood
PY  - 2003///
VL  - 102
SP  - 3727
EP  - 3736
M3  - 10.1182/blood-2003-02-0412
N1  - 10.1182/blood-2003-02-0412
UR  - http://dx.doi.org/10.1182/blood-2003-02-0412
ER  -

TY  - JOUR
AU  - Lewis, J. S.
TI  - Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation
JA  - J. Natl Cancer Inst.
PY  - 2005///
VL  - 97
SP  - 1746
EP  - 1759
ER  -

TY  - JOUR
AU  - Lu, M.
AU  - y-Lopez, R.
AU  - Nakajo, S.
AU  - Nakaya, K.
AU  - Jing, Y.
TI  - Expression of estrogen receptor [alpha], retinoic acid receptor [alpha] and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells
JA  - Oncogene
PY  - 2005///
VL  - 24
SP  - 4362
EP  - 4269
M3  - 10.1038/sj.onc.1208661
N1  - 10.1038/sj.onc.1208661
UR  - http://dx.doi.org/10.1038/sj.onc.1208661
ER  -

TY  - JOUR
AU  - Yue, W.
TI  - Tamoxifen versus aromatase inhibitors for breast cancer prevention
JA  - Clin. Cancer Res.
PY  - 2005///
VL  - 11
SP  - 9225s
EP  - 9230s
ER  -

TY  - JOUR
AU  - Nair, H. B.
TI  - Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation
JA  - Cancer Res.
PY  - 2005///
VL  - 65
SP  - 11164
EP  - 11173
M3  - 10.1158/0008-5472.CAN-05-1087
N1  - 10.1158/0008-5472.CAN-05-1087
UR  - http://dx.doi.org/10.1158/0008-5472.CAN-05-1087
ER  -

TY  - JOUR
AU  - Ratliff, T. L.
TI  - Mutation of the androgen receptor causes oncogenic transformation of the prostate
JA  - J. Urol.
PY  - 2005///
VL  - 174
SP  - 1149
M3  - 10.1097/01.ju.0000171853.20105.60
N1  - 10.1097/01.ju.0000171853.20105.60
UR  - http://dx.doi.org/10.1097/01.ju.0000171853.20105.60
ER  -

TY  - JOUR
AU  - Tao, J.
TI  - Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach
JA  - Br. J. Dermatol.
PY  - 2005///
VL  - 153
SP  - 715
EP  - 724
M3  - 10.1111/j.1365-2133.2005.06765.x
N1  - 10.1111/j.1365-2133.2005.06765.x
UR  - http://dx.doi.org/10.1111/j.1365-2133.2005.06765.x
ER  -